2-(3-chlorophenyl)-5-N-(3,5-difluorophenyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide
C20H16ClF2N5O2 — CID 118061948
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(3-chlorophenyl)-5-N-(3,5-difluorophenyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide
2-(3-chlorophenyl)-5-N-(3,5-difluorophenyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide (PubChem CID 118061948) has the molecular formula C20H16ClF2N5O2 and a molecular weight of 431.83 g/mol. Its IUPAC name is 2-(3-chlorophenyl)-5-N-(3,5-difluorophenyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide.
Molecular Properties
| Compound Name | 2-(3-chlorophenyl)-5-N-(3,5-difluorophenyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide |
|---|---|
| PubChem CID | 118061948 |
| Molecular Formula | C20H16ClF2N5O2 |
| Molecular Weight | 431.83 g/mol |
| Exact Mass | 431.10 |
| IUPAC Name | 2-(3-chlorophenyl)-5-N-(3,5-difluorophenyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide |
| SMILES | NC(=O)c1c(-c2cccc(Cl)c2)nn2c1CN(C(=O)Nc1cc(F)cc(F)c1)CC2 |
| InChI | InChI=1S/C20H16ClF2N5O2/c21-12-3-1-2-11(6-12)18-17(19(24)29)16-10-27(4-5-28(16)26-18)20(30)25-15-8-13(22)7-14(23)9-15/h1-3,6-9H,4-5,10H2,(H2,24,29)(H,25,30) |
| InChIKey | YNBZWCSPSLHSEX-UHFFFAOYSA-N |
| XLogP | 3.63 |
| TPSA | 93.25 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 431.83 |
| LogP ≤ 5 | 3.63 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118061948 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.